Clinical Trials | July 24, 2022
Merck opens microbiology application lab in Jigani, Bengaluru
Merck’s first microbiology application and training lab in India
Merck’s first microbiology application and training lab in India
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Manish led SeQuent since 2014 and played a major role in transforming the company
ExoBrite antibody conjugates are validated and optimized for bright and specific detection of exosome markers
Jublia (Efinaconazole) topical solution, 10% had annual sales of $292 million in the United States according to IQVIA data (IQVIA MAT May 2022).
Tobacco smoke increases infant morbidity and is fatal to a baby because it damages the baby’s organs
She joins Enveda from Gilead Sciences
Supports development and commercialization of complex oral drugs using sensitive molecules, including biologicals
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.
Up to $30m funding will be provided to advance an innovative vaccine technology that could protect against current and future SARS-CoV-2 variants and other SARS-like Betacoronaviruses.
Subscribe To Our Newsletter & Stay Updated
